Integra LifeSciences Holdings Corporation

NasdaqGS:IART Stok Raporu

Piyasa değeri: US$1.8b

Integra LifeSciences Holdings Yönetim

Yönetim kriter kontrolleri 4/4

Integra LifeSciences Holdings CEO'su Jan De Witte, Dec2021 tarihinde atandı, in görev süresi 2.92 yıldır. in toplam yıllık tazminatı $ 6.39M olup, şirket hissesi ve opsiyonları dahil olmak üzere 13.7% maaş ve 86.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.031% ine doğrudan sahiptir ve bu hisseler $ 549.82K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.6 yıl ve 11.5 yıldır.

Anahtar bilgiler

Jan De Witte

İcra Kurulu Başkanı

US$6.4m

Toplam tazminat

CEO maaş yüzdesi13.7%
CEO görev süresi2.9yrs
CEO sahipliği0.03%
Yönetim ortalama görev süresi3.6yrs
Yönetim Kurulu ortalama görev süresi11.5yrs

Son yönetim güncellemeleri

Recent updates

There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Nov 05
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Oct 24
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Sep 08
Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

Aug 21
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Jul 01
At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Integra LifeSciences Still Underperforming As Manufacturing Issues Linger

Jun 21

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

May 28
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

Feb 27
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Feb 11
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jan 14
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Dec 31
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Dec 03
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Nov 06
Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Oct 24
Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Sep 22
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Aug 15
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Jul 03
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jun 19
Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

May 05
Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Apr 07
These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

Mar 26
Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Mar 14
At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Feb 27
Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Feb 02
Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Jan 05
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

Dec 21
Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Dec 08
When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

CEO Tazminat Analizi

Jan De Witte'un ücretlendirmesi Integra LifeSciences Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$7m

Jun 30 2024n/an/a

US$24m

Mar 31 2024n/an/a

US$40m

Dec 31 2023US$6mUS$875k

US$68m

Sep 30 2023n/an/a

US$101m

Jun 30 2023n/an/a

US$131m

Mar 31 2023n/an/a

US$172m

Dec 31 2022US$9mUS$850k

US$181m

Sep 30 2022n/an/a

US$173m

Jun 30 2022n/an/a

US$166m

Mar 31 2022n/an/a

US$157m

Dec 31 2021US$899kUS$59k

US$169m

Tazminat ve Piyasa: Jan 'ın toplam tazminatı ($USD 6.39M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 5.43M ).

Tazminat ve Kazançlar: Jan 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Jan De Witte (60 yo)

2.9yrs

Görev süresi

US$6,388,756

Tazminat

Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Stuart Essig
Executive Chairman26.9yrsUS$422.52k2.27%
$ 40.3m
Jan De Witte
President2.9yrsUS$6.39m0.031%
$ 549.8k
Lea Knight
Executive VP & CFO1.4yrsUS$1.67m0.054%
$ 964.6k
Jeffrey Mosebrook
Senior VP of Finance & Principal Accounting Officer7.1yrsUS$1.25m0.047%
$ 830.1k
Eric Schwartz
Executive VP6yrsUS$1.62m0.082%
$ 1.5m
Robert Davis
Executive VP & President of Tissue Technologies11.9yrsUS$1.42m0.084%
$ 1.5m
Michael McBreen
Executive VP & President of Codman Specialty Surgical4.5yrsUS$2.83m0.075%
$ 1.3m
Stephen Leonard
Corporate VP of Global Operations & Supply Chain4.3yrsVeri yokVeri yok
Laurene Isip
Vice President of Global Corporate Communications & Public Relationsno dataVeri yokVeri yok
Ruth Fleming
Vice President of Global Marketingno dataVeri yokVeri yok
Chantal Veillon-Berteloot
Executive VP & Chief Human Resources Officer1.8yrsVeri yok0.032%
$ 560.6k
Mark Jesser
Corporate VP & Chief Digital Officer2.8yrsVeri yokVeri yok

3.6yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: IART 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.6 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Stuart Essig
Executive Chairman26.9yrsUS$422.52k2.27%
$ 40.3m
Jan De Witte
President2.9yrsUS$6.39m0.031%
$ 549.8k
Raymond Murphy
Independent Director15.6yrsUS$297.54k0.11%
$ 1.9m
Christian Schade
Independent Director18.8yrsUS$293.28k0.082%
$ 1.5m
Barbara Hill
Independent Presiding Director11.5yrsUS$342.54k0.18%
$ 3.1m
Keith N. Bradley
Independent Director32.8yrsUS$306.31k0.091%
$ 1.6m
Jeffrey Graves
Independent Directorless than a yearUS$90.68k0.016%
$ 287.3k
Shaundra Clay
Independent Director3.6yrsUS$260.04k0.028%
$ 504.2k
Renee Lo
Independent Director2.3yrsUS$297.54k0.021%
$ 371.5k

11.5yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IART 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 11.5 yıldır).